Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L5FY
|
|||
Former ID |
DAP000480
|
|||
Drug Name |
Metipranolol
|
|||
Synonyms |
Disorat; Methypranol; Metipranololum; Trimepranol; Turoptin; BM-01004; Betanol (TN); Disorat (TN); Metipranololum [INN-Latin]; OptiPranolol (TN); Trimepranol (TN); VUAB-6453; VUFB-6453; Metipranolol (USAN/INN); Metipranolol [USAN:BAN:INN]; [4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-2,3,6-trimethylphenyl] acetate; Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, 1-acetate; Phenol, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, 1-acetate (9CI); Phenol,4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-2,3,6-trimethyl-, (+-)-, 1-acetate; (+-)-1-(4-Hydroxy-2,3,5-trimethylphenoxy)-3-(isopropylamino)-2-propanol 4-acetate; (RS)-4-(2-Hydroxy-3-isopropylaminopropoxy)-2,3,6-trimethylphenyl acetat; 1-(4-Acetoxy-2,3,5-Trimethylphenoxy)-3-Isopropylamino-2-Propanol; 1-(4-Hydroxy-2,3,5-trimethylphenoxy)-3-(isopropylamino)-2-propanol 4-acetate; 2-Propanol, 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3-(isopropylamino)-, 4-acetate; 4-(2-Hydroxy-3-((1-methylethyl)-amino)propoxy)-2,3,6-trimethylphenol 1-acetate; 4-[2-hydroxy-3-(isopropylamino)propoxy]-2,3,6-trimethylphenyl acetate; 62164P
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Open-angle glaucoma [ICD-11: 9C61] | Approved | [1], [2], [3] | |
Therapeutic Class |
Antihypertensive Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H27NO4
|
|||
Canonical SMILES |
CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O
|
|||
InChI |
1S/C17H27NO4/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4/h7,10,15,18,20H,8-9H2,1-6H3
|
|||
InChIKey |
BQIPXWYNLPYNHW-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 22664-55-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
10117, 6091362, 7849433, 7979966, 8172196, 14923317, 29215465, 29215466, 34673602, 46505935, 50023321, 50281609, 53789605, 57311237, 85209951, 103400859, 104310958, 117554330, 118200154, 127552988, 134337773, 134994195, 135610082, 137164582, 141191904, 143311431, 144205272, 152135018, 160843914, 160964547, 165396045, 178103813, 179150187, 184547567, 184547842, 226412703, 250133630
|
|||
ChEBI ID |
CHEBI:6897
|
|||
ADReCS Drug ID | BADD_D01441 | |||
SuperDrug ATC ID |
S01ED04
|
|||
SuperDrug CAS ID |
cas=022664557
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor beta-1 (ADRB1) | Target Info | Antagonist | [4] |
KEGG Pathway | Calcium signaling pathway | |||
cGMP-PKG signaling pathway | ||||
cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
Endocytosis | ||||
Adrenergic signaling in cardiomyocytes | ||||
Gap junction | ||||
Salivary secretion | ||||
Dilated cardiomyopathy | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
Beta1 adrenergic receptor signaling pathway | ||||
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Adrenoceptors | |||
G alpha (s) signalling events | ||||
WikiPathways | Monoamine GPCRs | |||
Calcium Regulation in the Cardiac Cell | ||||
GPCRs, Class A Rhodopsin-like | ||||
Endothelin Pathways | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7239). | |||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 3 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 075720. | |||
REF 4 | Invited review: Neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma. J Ocul Pharmacol Ther. 2005 Jun;21(3):175-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.